查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1913377

蛋白A樹脂市場：市場機會、成長促進因素、產業趨勢分析及預測（2026-2035）

Protein A Resins Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035
出版日期: | 出版商: Global Market Insights Inc. | 英文 148 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球蛋白A樹脂市場預計到2025年將達到14億美元，到2035年將達到25億美元，年複合成長率為5.9%。

Protein A 樹脂市場-IMG1

市場成長與生物製藥行業的快速擴張和生物製藥產量的不斷提高密切相關。 Protein A 樹脂作為一種高親和性層析法介質，可高效純化生產過程中的單株抗體和免疫球蛋白。對生物療法的持續成長的需求正推動生產商擴大產能，這直接增加了他們對高性能純化解決方案的依賴。重點地區人口老化導致需要先進生物療法和疫苗的長期健康問題發生率上升，進一步強化了對 Protein A 樹脂的需求。對生命科學研究的持續投入、生物製藥生產基礎設施的不斷完善以及對產品品質和均一性的嚴格監管要求，都在推動市場穩步擴張。這些因素共同促成了 Protein A 樹脂成為現代生物製藥生產流程中不可或缺的一部分。

市場覆蓋範圍
開始年份 2025
預測期 2026-2035
初始市場規模 14億美元
市場規模預測 25億美元
複合年成長率 5.9%

重組蛋白A樹脂預計在2025年將佔據64.8%的市場佔有率，這主要得益於其卓越的結合效率、更高的穩定性以及在大規模生物製藥生產環境中的穩定性能。技術進步提高了樹脂的耐久性和運作，從而幫助生產商最佳化成本。

由於瓊脂糖基質具有優異的機械性能、良好的流動性和適用於工業規模層析法系統的特性，預計到 2025 年，瓊脂糖基材產品市場佔有率將達到 63.2%。

受強勁的生物製藥研究活動和抗體療法的持續開發推動，美國蛋白 A 樹脂市場預計將從 2025 年的 5.421 億美元成長到 2035 年的 9.524 億美元。

目錄

第1章：分析方法和範圍

第2章執行摘要

第3章業界考察

  • 產業生態系分析
  • 產業影響因素
    • 促進要素
      • 疫苗和治療性抗體的需求不斷成長
      • 慢性病發生率呈上升趨勢
      • 擴大藥物發現與研發活動
      • 蛋白質A樹脂技術進展
    • 產業潛在風險與挑戰
      • 單株抗體純化替代方法的興起
      • 基體樹脂高成本
    • 市場機遇
      • 新興市場的地域擴張
      • 永續性和成本效益
  • 成長潛力分析
  • 監管環境
    • 北美洲
    • 歐洲
    • 亞太地區
  • 科技趨勢
    • 當前技術趨勢
    • 新興技術
  • 專利分析
  • 未來市場趨勢
  • 定價分析
  • 波特五力分析
  • PESTEL 分析

第4章 競爭情勢

  • 介紹
  • 公司市佔率分析
    • 按地區
      • 世界
      • 北美洲
      • 歐洲
      • 亞太地區
  • 企業矩陣分析
  • 主要企業的競爭分析
  • 競爭定位矩陣
  • 主要趨勢
    • 企業合併（M&A）
    • 夥伴關係與合作
    • 新產品發布
    • 擴張計劃

第5章 按產品分類的市場估算與預測（2022-2035 年）

  • 天然蛋白A樹脂
  • 重組蛋白A樹脂

6. 依基材類型分類的市場估算與預測（2022-2035 年）

  • 瓊脂糖基材
  • 玻璃/矽膠基材
  • 有機聚合物基材

第7章 按應用領域分類的市場估算與預測（2022-2035 年）

  • 免疫沉澱分析法
  • 抗體純化

第8章 依最終用途分類的市場估算與預測（2022-2035 年）

  • 製藥和生物製藥公司
  • CRO/CDMO
  • 學術和研究機構
  • 其他最終用戶

第9章 各地區市場估算與預測（2022-2035 年）

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國

第10章：公司簡介

  • Agarose Beads Technologies
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Danaher Corporation
  • GenScript
  • Merck
  • Purolite
  • Repligen Corporation
  • Takara Bio
  • Thermo Fisher Scientific
  • Tosoh Bioscience
簡介目錄
Product Code: 1146

The Global Protein A Resins Market was valued at USD 1.4 billion in 2025 and is estimated to grow at a CAGR of 5.9% to reach USD 2.5 billion by 2035.

Protein A Resins Market - IMG1

Market growth is linked to the rapid expansion of the biopharmaceutical industry and the rising production of biologic drugs. Protein A resins serve as high-affinity chromatography media that enable efficient purification of monoclonal antibodies and immunoglobulins during manufacturing. As demand for biologic therapies continues to rise, manufacturers are scaling up production capacities, which directly increases reliance on high-performance purification solutions. Aging populations across major regions are contributing to higher incidence rates of long-term health conditions that require advanced biologic treatments and vaccines, further strengthening demand for protein A resins. Continued investment in life sciences research, expansion of biopharmaceutical manufacturing infrastructure, and strict regulatory requirements for product quality and consistency are reinforcing steady market expansion. Together, these factors position protein A resins as an essential component within modern biologics manufacturing workflows.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$1.4 Billion
Forecast Value$2.5 Billion
CAGR5.9%

The recombinant protein A resins segment accounted 64.8% share in 2025, supported by their superior binding efficiency, improved stability, and consistent performance in large-scale biologics production environments. Technological progress has enhanced resin durability and operational lifespan, helping manufacturers optimize costs.

The agarose-based matrix products segment held 63.2% share in 2025, driven by their strong mechanical properties, favorable flow behavior, and suitability for industrial-scale chromatography systems.

U.S. Protein A Resins Market is expected to grow from USD 542.1 million in 2025 to USD 952.4 million by 2035, supported by strong biopharmaceutical research activity and rising development of antibody-based therapeutics.

Key companies operating in the Global Protein A Resins Market include Merck, Repligen Corporation, Thermo Fisher Scientific, Danaher Corporation, Tosoh Bioscience, Bio-Rad Laboratories, Agilent Technologies, Purolite, GenScript, Takara Bio, and Agarose Beads Technologies. Companies in the Global Protein A Resins Market are strengthening their market position through continuous investment in resin innovation to improve binding capacity, durability, and chemical resistance. Strategic collaborations with biopharmaceutical manufacturers help align product development with evolving production needs. Firms are expanding manufacturing capabilities to support large-scale biologics production and ensure reliable supply chains. Focusing on regulatory compliance, quality consistency, and cost optimization enables suppliers to meet stringent industry standards.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 360º synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional trends
    • 2.2.2 Product trends
    • 2.2.3 Matrix type trends
    • 2.2.4 Application trends
    • 2.2.5 End use trends
  • 2.3 CXO perspectives: Strategic imperatives
    • 2.3.1 Key decision points for industry executives
    • 2.3.2 Critical success factors for market players
  • 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising demand for vaccine and therapeutic antibodies
      • 3.2.1.2 Increasing prevalence of chronic diseases
      • 3.2.1.3 Growing drug discovery and research and development activity
      • 3.2.1.4 Technology advancements in protein A resins
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Rise in alternative methods for the purification of monoclonal antibodies
      • 3.2.2.2 High cost of the matrix resins
    • 3.2.3 Market opportunities
      • 3.2.3.1 Regional expansion in emerging markets
      • 3.2.3.2 Sustainability and cost-effectiveness
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
  • 3.5 Technology landscape
    • 3.5.1 Current technological trends
    • 3.5.2 Emerging technologies
  • 3.6 Patent analysis
  • 3.7 Future market trends
  • 3.8 Pricing analysis
  • 3.9 Porter's analysis
  • 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company market share analysis
    • 4.2.1 Global
    • 4.2.2 North America
    • 4.2.3 Europe
    • 4.2.4 Asia Pacific
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key development
    • 4.6.1 Mergers and acquisitions
    • 4.6.2 Partnerships and collaborations
    • 4.6.3 New product launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)

  • 5.1 Key trends
  • 5.2 Natural protein A resin
  • 5.3 Recombinant protein A resin

Chapter 6 Market Estimates and Forecast, By Matrix Type, 2022 - 2035 ($ Mn)

  • 6.1 Key trends
  • 6.2 Agarose-based matrix
  • 6.3 Glass or silica gel-based matrix
  • 6.4 Organic polymer-based matrix

Chapter 7 Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)

  • 7.1 Key trends
  • 7.2 Immunoprecipitation
  • 7.3 Antibody purification

Chapter 8 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

  • 8.1 Key trends
  • 8.2 Pharmaceutical and biopharmaceutical companies
  • 8.3 CROs and CDMOs
  • 8.4 Academic and research institutes
  • 8.5 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 India
    • 9.4.3 Japan
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 South Africa
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 Agarose Beads Technologies
  • 10.2 Agilent Technologies
  • 10.3 Bio-Rad Laboratories
  • 10.4 Danaher Corporation
  • 10.5 GenScript
  • 10.6 Merck
  • 10.7 Purolite
  • 10.8 Repligen Corporation
  • 10.9 Takara Bio
  • 10.10 Thermo Fisher Scientific
  • 10.11 Tosoh Bioscience